Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC Cyclo(L-arginyl-L-leucyl-D-seryl-L-lysyl-L-a-aspartyl-L-lysyl) (TFA) | 99.7% | 841.88 | 10 MG
SDP

Catalog No. 5000423804
Encompass_Preferred

Cyclo(RLsKDK) (TFA) is a specific inhibitor of metalloproteinase ADAM8, with an IC50 value of 182 nM. This compound holds potential for therapeutic applications in various inflammatory diseases and different types of cancer.

  • Inhibits metalloproteinase ADAM8 with an IC50 of 182 nM.
  • Shows potential for applications in inflammatory diseases and cancer.
  • Promotes ADAM8 activation and CD23 shedding.
  • Increases the activity of pro-ADAM8.
  • Causes ERK1/2 phosphorylation.
  • Reduces cell invasion.
  • Significantly reduces tumor load in in vivo models.
  • Improves the survival rate in pancreatic ductal adenocarcinoma models.
  • Reduces soluble ADAM8 content and metastasis in PDAC models.

Catalog No. 50-004-23804 Supplier Medchemexpress LLC Supplier No. HYP1676A10MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Cyclo(RLsKDK) (TFA) is a specific inhibitor of metalloproteinase ADAM8, with an IC50 value of 182 nM. This compound holds potential for therapeutic applications in various inflammatory diseases and different types of cancer.

  • Inhibits metalloproteinase ADAM8 with an IC50 of 182 nM.
  • Shows potential for applications in inflammatory diseases and cancer.
  • Promotes ADAM8 activation and CD23 shedding.
  • Increases the activity of pro-ADAM8.
  • Causes ERK1/2 phosphorylation.
  • Reduces cell invasion.
  • Significantly reduces tumor load in in vivo models.
  • Improves the survival rate in pancreatic ductal adenocarcinoma models.
  • Reduces soluble ADAM8 content and metastasis in PDAC models.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.